BioCentury
ARTICLE | Clinical News

Intuniv guanfacine GXR regulatory update

June 25, 2007 7:00 AM UTC

SHP received an approvable letter from FDA for Intuniv guanfacine (formerly Connexyn) extended-release tablets to treat ADHD in children and adolescents aged 6-17. The company said that FDA did not r...